Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists probe mysterious bone pain in rare disorder

NCT ID NCT07476768

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This study aims to understand why people with fibrous dysplasia of bone or McCune-Albright syndrome experience chronic pain. Researchers will compare pain responses in 40 adults (20 patients and 20 healthy volunteers) using heat and cold tests. The goal is to see if the nervous system becomes overly sensitive, which could guide better pain treatments in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

39 people

The number who actually took part.

Started

Apr 2026

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * For patients : * Male or female over 18 years of age with fibrous dysplasia/McCune-Albright syndrome diagnosed by a rheumatologist. * Mentally and legally able to provide informed consent to participate in the study. * Affiliated with a health insurance system. * For healthy volunteers : * Male or female over 18 years of age. * Matched to patients by age and sex. * Mentally and legally able to provide informed consent to participate in the study. * Affiliated with a health insurance system. Exclusion Criteria: * For patients : * Medical and/or surgical history considered by the investigator or delegated physician to be incompatible with study procedures (e.g., amputation or physical limitation preventing completion of pain assessment tests). * Recurrent pain at sites planned for stimulation during thermal and mechanical testing (forearms or palms). * Presence of anxiety and/or depression defined as Hospital Anxiety and Depression Scale (HADS) score \>11. * Use of analgesic medication within the week preceding inclusion. * Use of complementary treatments for analgesic purposes (e.g., vitamins, herbal products, cannabinoids). * Individuals under legal protection (guardianship or trusteeship) or deprived of liberty. * Pregnant or breastfeeding women. * Refusal to participate. * For heathly volunteers : * Medical and/or surgical history considered by the investigator or delegated physician to be incompatible with study procedures (e.g., amputation or physical limitation preventing completion of pain assessment tests). * Presence of sleep disorders defined as Pittsburgh Sleep Quality Index (PSQI) score \>5. * Presence of anxiety and/or depression defined as HADS score \>11. * Use of analgesic medication within the week preceding inclusion. * Use of complementary treatments for analgesic purposes (e.g., vitamins, herbal products, cannabinoids). * Individuals under legal protection (guardianship or trusteeship) or deprived of liberty. * Pregnant or breastfeeding women. * Refusal to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fibrous dysplasia of bone are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU clermont-Ferrand

    Clermont-Ferrand, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.